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Ubiquitin is post-translationally modified by phos-
phorylation at several sites, but the consequences
of these modifications are largely unknown. Here,
we synthesize multi-milligram quantities of ubiquitin
phosphorylated at serine 20, serine 57, and serine
65 via genetic code expansion. We use these phos-
phoubiquitins for the enzymatic assembly of 20
isomeric phosphoubiquitin dimers, with different
sites of isopeptide linkage and/or phosphorylation.
We discover that phosphorylation of serine 20 on
ubiquitin converts UBE3C from a dual-specificity E3
ligase into a ligase that primarily synthesizes K48
chains. We profile the activity of 31 deubiquitinases
on the isomeric phosphoubiquitin dimers in 837 reac-
tions, and we discover that phosphorylation at
distinct sites in ubiquitin can activate or repress
cleavage of a particular linkage by deubiquitinases
and that phosphorylation at a single site in ubiquitin
can control the specificity of deubiquitinases for
distinct ubiquitin linkages.INTRODUCTION
The post-translational modification of proteins with ubiquitin (Ub)
modulates an expanding array of cellular processes (Komander
and Rape, 2012). Ub is attached to a target protein through the
formation of an isopeptide bond between a lysine in the target
protein and the C terminus of the Ub. A cascade of enzymes
(E1s, E2s, and E3s) directs protein ubiquitination: Ub is first acti-
vated, as a thioester conjugate to a cysteine residue in an E1-
activating enzyme, and is then transferred to the active site
cysteine of an E2-conjugating enzyme, before it is conjugated
to the target protein with the help of an E3 ligase. The E3 may
either activate direct transfer of Ub from the E2 (RING and
U-box E3 ligases), or it may transiently accept Ub from the E2
to form an E3-Ub intermediate before transfer of Ub to the target
amine (RBR and HECT E3 ligases) (Berndsen and Wolberger,1180 Cell Reports 16, 1180–1193, July 26, 2016 ª 2016 MRC Labora
This is an open access article under the CC BY license (http://creative2014). In human cells there are two E1s, 40 E2s, and >600
E3s (Clague et al., 2015).
The action of the E1, E2, and E3 cascade is counteracted by
deubiquitinases (DUBs) that cleave the isopeptide bond be-
tween the target protein and Ub. There are five established
families of DUBs: Ub-specific proteases (USPs), Ub C-terminal
hydrolases (UCHs), ovarian tumor proteases (OTUs), Jose-
phins, and JAMMs (Komander et al., 2009). The interplay be-
tween the specificity of the E1, E2, and E3 systems and the
specificity of DUBs defines the ubiquitinated proteome, and
factors that alter the activity and specificity of these enzymes
reconfigure the ubiquitinated proteome and alter biological
outcomes.
Many proteins have been identified as targets of ubiquitina-
tion. Proteins can be mono-ubiquitinated or modified with Ub
polymers, in which Ub is linked via an isopeptide bond between
the C terminus of one monomer and a lysine residue (K6, K11,
K27, K29, K33, K48, or K63) or via a peptide bond to the N termi-
nus (M1) of another monomer.
Ub linkages have been identified in cells at varying abun-
dances (Kulathu and Komander, 2012). Because of the low
abundance of Ub chains (Kaiser et al., 2011) and the challenge
of purifying specific Ub linkage isomers from cells, the develop-
ment of methods for the synthesis of well-defined Ub chains
(Faggiano et al., 2016; Kumar et al., 2010; Virdee et al., 2010)
has been crucial for characterizing the structural and biochem-
ical properties of Ub chains. The characterization of atypical
Ub chains has often preceded an understanding of their physio-
logical significance, and biochemical and structural data for Ub
chains of unknown function continue to inform in vivo experi-
ments aimed at addressing physiological significance (Bremm
et al., 2010; Hospenthal et al., 2013; Kristariyanto et al., 2015;
Michel et al., 2015).
Ub is a target for post-translational modifications, including
acetylation (Ohtake et al., 2015) and phosphorylation (Kane
et al., 2014; Kazlauskaite et al., 2014; Koyano et al., 2014).
Several sites of phosphorylation (Thr7, Thr12, Thr14, Ser20,
Ser57, Tyr59, Ser65, and Thr66) have been identified on Ub
within mammalian cells (Herhaus and Dikic, 2015).
We recently reported the directed evolution of SepRS/
tRNACUA pairs (Rogerson et al., 2015) that function with amutant
of EF-Tu (Park et al., 2011) for the efficient genetic encoding oftory of Molecular Biology.
commons.org/licenses/by/4.0/).
phosphoserine and its non-hydrolyzable analog in response to
an amber codon, which can be introduced into a gene of interest
at a desired position (Rogerson et al., 2015). Here we use this
approach to synthesize phosphoubiquitin isomers bearing phos-
phorylation at the three serines in Ub that are modified in vivo
(serine 20, serine 57, and serine 65).
The physiological significance for serine 65 phosphorylation
is the most well-established of any phosphorylation in Ub.
Ser65 phosphorylation on Ub is installed by PINK1, which
also phosphorylates the E3 ligase Parkin (Kane et al., 2014;
Kazlauskaite et al., 2014; Kondapalli et al., 2012; Koyano
et al., 2014; Lai et al., 2015; Shiba-Fukushima et al., 2012). Mu-
tations in PINK1 and Parkin are the most common cause of
autosomal recessive Parkinson’s disease (Corti et al., 2011;
Valente et al., 2004). It appears that phosphorylation of both
Parkin and Ub is required to activate Parkin and to ubiquitinate
and clear damaged mitochondria from cells (Kumar et al., 2015;
Lazarou et al., 2015). Ser65 phosphorylation is detected
as <1.5% of global Ub in human cells, but the fraction of phos-
phorylated Ub at the mitochondria can reach 10%–20%. These
observations further demonstrate that low global levels of
phosphoubiquitin species are consistent with physiologically
relevant function.
Ub phosphorylated at Ser65 may be prepared by enzymatic
phosphorylation with PINK1 (Wauer et al., 2015). However, for
the other serine phosphorylation sites on Ub, the kinases that
install the phosphorylation are unknown, and the molecular
consequences of Ub phosphorylation remain uncharacterized.
Serine 57 is the major (most abundant) phosphorylation site
on Ub (Swaney et al., 2015), and it has been found repeatedly
in independent studies in yeast and mammalian cells (Bennet-
zen et al., 2010; Bian et al., 2014; Malik et al., 2009; Phanstiel
et al., 2011; Sharma et al., 2014; Swaney et al., 2015; Ville´n
et al., 2007; Zhou et al., 2013). Recently, serine 57 phosphory-
lation was shown to be globally upregulated in response to
oxidative stress (Swaney et al., 2015). Serine 20 phosphoryla-
tion has been detected repeatedly in human, mouse, and rat
(Choudhary et al., 2009; Lundby et al., 2012; Manes et al.,
2011).
Here we used genetic code expansion to express and purify
multi-milligram quantities of Ub bearing homogeneous phos-
phorylation at Ser20 (Ub [pSer20]), Ser57 (Ub [pSer57]), and
Ser65 (Ub [pSer65]) from E. coli and to solve the structure of
Ub (pSer20). We determined the consequences of each phos-
phorylation for E1 activation and E2 conjugation by 18 E2s. We
assembled and purified 20 phosphorylated Ub dimers, with
distinct sites of peptide linkage (M1, K6, K11, K29, K33, K48,
and K63) and phosphorylation (Ser20, Ser57, and Ser65), using
the E2/E3 combinations reported for the synthesis of unmodified
Ub chains. In the process of assembling and characterizing
phosphoubiquitin chains, we discovered that phosphorylation
of serine 20 on Ub converts UBE3C from a dual-specificity E3
ligase into a ligase that primarily synthesizes K48 chains. DUB
assays with phosphorylated Ub dimers revealed that (1) phos-
phorylation at distinct sites on Ub can control DUB-mediated
cleavage of a given Ub linkage, and that (2) phosphorylation at
each site in Ub can control the specificity with which DUBs
cleave different Ub linkages.RESULTS
Production of Ub (pSer20), Ub (pSer57), and Ub (pSer65)
We expressed each phosphorylated Ub variant from the corre-
sponding Ub (Ser XX TAG)-His6 gene, where XX defines the
site of serine phosphorylation in the protein, TAG is the amber
codon, and His6 encodes the hexahistidine tag. Phosphoserine
was directed into the protein using an evolved SepRS/tRNACUA
pair, an approach that we previously demonstrated allows the
production of homogeneous and site-specifically phosphory-
lated Ub and other phosphoproteins (Rogerson et al., 2015).
Ub (pSer20), Ub (pSer57), and Ub (pSer65) were purified with
yields of 1.5, 0.5, and 24 mg/l, respectively (Figure 1A). We
also expressed and purified the corresponding K48R mutants
of Ub required for the assembly of K6-linked Ub chains (Hospen-
thal et al., 2013). Electrospray ionization mass spectrometry
(ESI-MS) confirmed the phosphorylation of each Ub (Figure 1B),
and targeted MS confirmed the site of phosphorylation (Kirkpa-
trick et al., 2006) (Data S1). While a previous report also claimed
to have made phosphoubiquitin species using an unevolved
SepRS/tRNACUA pair (Ordureau et al., 2015; Park et al., 2011),
no characterization of phosphoserine incorporation was re-
ported. Moreover, we previously demonstrated that the un-
evolved synthetase/tRNA pair is 20 times less efficient than the
evolved pair we used here (Rogerson et al., 2015), and others
previously demonstrated that the unevolved SepRS/tRNACUA
pair incorporates natural amino acids into proteins in response
to the amber codon, leading to heterogeneous protein products
(Heinemann et al., 2012), which make interpreting biochemical
experiments challenging.
We obtained crystals for Ub (pSer20), which diffracted to
1.55 A˚ (Table S1) and showed clear density for the phosphate
group (Figure 1C). This underscores the quantity and purity of
proteins obtained using the evolved SepRS/tRNACUA pair (Rog-
erson et al., 2015). The fold of the phosphorylated protein is
comparable to that of unphosphorylated Ub (root-mean-square
deviation [RMSD] to 1UBQ [Vijay-Kumar et al., 1987] residues
1–72 is 0.8 A˚; Figure 1D), though the charge distribution on
one face of the molecule is perturbed (Figure 1E).
Phosphorylation at Ser20, Ser57, or Ser65 Does Not
Affect the Loading of E2s with Ub
To test whether phosphorylation at serine in position 20, 57, or 65
influenced the first two steps in the ubiquitination cascade, E2-
charging reactions containing an E1 (Ube1), ATP, and 18
different E2s were performed (Figures 2A–2R). We did not
observe differences in charging efficiency among Ub (pSer20),
Ub (pSer57), Ub (pSer65), and unmodified Ub. We conclude
that phosphorylation at Ser20, Ser57, or Ser65 does not affect
the first two steps of the ubiquitination cascade with the E2s
tested. Our results define the effects of Ser20 and Ser57 phos-
phorylation of Ub on E2 charging, and they are consistent with
previous observations, using a subset of the E2s we have inves-
tigated (Wauer et al., 2015), for Ser65 phosphorylation.
Synthesis of Isomeric Phosphoubiquitin Chains
Next we asked whether Ub (pSer20), Ub (pSer57), and Ub
(pSer65) chains linked through M1, K6, K11, K29, K33, K48, orCell Reports 16, 1180–1193, July 26, 2016 1181
AC
D E
B Figure 1. Production and Characterization
of Ub (pSer20), Ub (pSer57), and Ub (pSer65)
(A) Coomassie staining of equal amounts of un-
modified Ub and phosphorylated Ub. 20, 57, and
65 designate the phosphorylated serine residue
on Ub.
(B) ESI-MS demonstrates the quantitative incor-
poration of pSer into Ub (Ub: expected 8,564.8 Da,
observed 8,564.78 Da; Ub (pSer20): expected
8,644.78 Da, observed 8,644.42 Da; Ub (pSer57):
expected 8,644.78 Da, observed 8,644.21 Da; and
Ub (pSer65): expected 8,644.78 Da, observed,
8,644.05 Da).
(C) 2FoFc map around the phosphate of Ub
(pSer20) contoured at 1.3 sigma is shown.
(D) Alignment of the structure of Ub (pSer20) (yel-
low) and a Ub reference structure (PDB: 1UBQ;
Vijay-Kumar et al., 1987) (light blue), RMSD for
residues 1–72 = 0.8 A˚ (calculated with DALI [Ha-
segawa and Holm, 2009]). The phosphate atom is
displayed in orange and oxygen atoms are in red.
(E) Electrostatic surface potential changes on
the surface of Ub, unmodified (top) and pSer20
(bottom) in similar orientation. Potentials were
calculated with the APBS plug-in within PyMOL,
using established phosphoserine parameters
(Steinbrecher et al., 2012).
See also Table S1.K63onUbcanbe formedusingcombinationsof enzymes that are
known to assemble these chains with unmodified Ub (Faggiano
et al., 2016). We followed the extent of Ub chain formation as a
function of time by SDS-PAGE (Figure 3) and the composition
of the chain formed by targetedMS,with isotopically labeled, ab-
solute quantitation (AQUA) peptide standards (Kirkpatrick et al.,
2006) (henceforth referred to as targeted MS) (Data S1).
For the enzymes that assemble M1-linked linear Ub chains
(Ube1, UBE2L3, and HOIP), the extent of chain formation was
not attenuated with Ub (pSer20) and Ub (pSer57) (Figure 3A).
However, we observed a decrease in chain formation for Ub
(pSer65), consistent with previous observations (Wauer et al.,
2015). Phosphorylation at position 20 of Ub increased the frac-
tion of K11 linkages formed (from undetectable levels with un-
modified Ub to 9% with Ub [pSer20]), while phosphorylation at
position 65 increased the fraction of K33 linkages formed to
10% with Ub (pSer65) (Data S1).
For the enzymes that assemble K6 chains (Ube1, UBE2L3, and
NleL), using K48Rmutants of Ub to avoid forming K48 chains, we1182 Cell Reports 16, 1180–1193, July 26, 2016observed no substantial differences in the
extent of Ub chain formation with the
K48R Ub species tested (Figure 3B).
However, K11 linkages were formed
with Ub (K48R, pSer20) (7%) and K63
linkages were formed with Ub (K48R,
pSer65) (10%) (Data S1).
K11- and K63-linked Ub chains can be
formed by Ube1 and UBE2S-UBP. The
addition of AMSH removes K63 chains
leaving pure K11-linked Ub.We observed
no substantial effect on the extent ofchain formation with Ub (pSer20), Ub (pSer57), or Ub (pSer65)
(Figure 3C), and Ub (pSer20) and Ub (pSer57) predominantly
formed K11 chains (Data S1). However, Ub (pSer65) led to
33% K11 linkages and 62% K63 linkages (Data S1). These ob-
servations are consistent with our DUB assays (Figure 5), which
revealed that AMSH does not cleave K63-linked Ub (pSer65) di-
mers (Figure 5G). We conclude that Ube1 and UBE2S-UBP form
a mixture of K11- and K63-linked Ub (pSer65), which is not
further modified by AMSH.
Amixture of K29- and K48-linked chains can be assembled by
Ube1, UBE2D3, and UBE3C. Addition of the DUB vOTU cleaves
K48 chains in this mixture, leaving pure K29 chains (Kristariyanto
et al., 2015). We observed a striking decrease in the extent of
chain formation for Ub (pSer20) when incubated with Ube1,
UBE2D3, UBE3C, and vOTU (Figure 3D). Further investigation
revealed that UBE3C forms Ub (pSer20) chains in the absence
of vOTU (Figures 4A and S1), and these chains contain K48 link-
ages, but not K29 linkages (Figures 4A–4C). Our results reveal
that Ub that is phosphorylated on Ser20 is a substrate for the
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Figure 2. E1 Activation and E2 Charging Are Not Affected by Serine Phosphorylation in Ub
(A–R) Commassie staining of E2-charging reactions containing an E1 (Ube1), ATP, 18 different E2s, and Ub, Ub (pSer20), Ub (pSer57), or Ub (pSer65) after 1 hr
(A–J, L, P, and R) or 5 min (K, M–O, and Q) incubation at 30C. Ub, Ubiquitin; E2Ub, Thioester-linked E2-Ub pair; Ub-E2Ub, Thioester-linked E2-Ub pair with
one covalently E2 attached Ub; 20, 57, and 65 designate the phosphorylated serine residue on Ub. See also Figure S2 and Table S2.
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(legend on next page)
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K48 ligase activity of UBEC3, but it is not a substrate for the K29
ligase activity of UBE3C. We conclude that Ser20 phosphoryla-
tion on Ub changes UBE3C from a dual-specificity ligase that
makes K48- and K29-linked chains with unmodified Ub to a
ligase that makes predominantly Ser20 phosphorylated K48-
linked chains with Ser20 phosphorylated Ub (Figure 6B). In
contrast, phosphorylation at Ser57 or Ser65 of Ub has more
modest effects on UBE3C ligase activity (Data S1).
A mixture of K33-, K11-, and K48-linked chains can be assem-
bled with Ube1, UBE2D1, and AREL1. To create pure K33
chains, the DUBs Cezanne-EK and OTUB1 are added to hydro-
lyze K11 and K48 chains, respectively, and leave pure K33
chains (Michel et al., 2015). The phosphorylation sites investi-
gated did not substantially influence chain formation with these
enzymes (Figure 3E). Moreover, most of the Ub linkages formed
were at K33 for Ub (pSer20), Ub (pSer57), or Ub (pSer65) and Ub
(Data S1). However, consistent with our observation that K11-
linked Ub (pSer20) is a worse substrate for Cezanne than Ub
(Figure 5C), we observed 7% of K11 linkages for Ub (pSer20).
We used an E1/E2 combination (Ube1 and UBE2R1) that as-
sembles K48 chains with Ub for chain assembly with each of
the phosphorylated Ubs. We found that chain assembly was
attenuated for Ub (pSer65) (Figures 3F and S2). Phosphorylation
of Ser65 in Ub led to a decrease in the fraction of K48 chains
formed and an increase in the formation of K63 linkages (from
undetectable levels for Ub to 12% of linkages for Ub [pSer65];
Data S1), in qualitative agreement with previous work (Wauer
et al., 2015). We found that Ser20 phosphorylation also
decreased the fraction of K48 linkages and led to an increase
in K6 linkages with Ube1 and UBE2R1 (Data S1).
We used an E1/E2 combination (Ube1, UBE2N, and UBE2V1)
that assembles K63 chains with unmodified Ub for chain assem-
bly with each of the phosphorylated Ubs.We observed amodest
attenuation of chain assembly for Ub (pSer20) and Ub (pSer57)
and a more dramatic attenuation of chain assembly for Ub
(pSer65) (Figure 3G). However, phosphorylation at the sites
tested did not affect the linkage composition (Data S1). We
conclude that phosphorylation of Ub affects the kinetics of K63
chain formation with these enzymes but does not substantively
affect the composition of the chains formed.
Phosphorylation of Ub at Ser20, Ser57, and Ser65
Controls DUB Specificity
Next we addressed the consequences of Ub phosphorylation for
DUB activity and specificity. We purified dimers of Ub, dimers ofFigure 3. The Synthesis of Ub Chains Is Differentially Affected by Phos
Chain assembly time course reactions are shown. All reactions contained Ube1
Blue Prestained Protein Standards (BioRad).
(A) M1 chain assembly. Time (left to right): 1, 5, 10, 20, 30, and 40 min.
(B) K6 chain assembly. UbK48R, UbK48R (pSer20), UbK48R(pSer57), or UbK48
and 60 min.
(C) K11 chain assembly. The DUB AMSH was added after the 6 hr time point. Ti
(D) K29 chain assembly. Time (left to right): 5, 15, 60, 180, and 360 min and over
(E) K33 chain assembly. The DUBs OTUB1 and Cezanne EK were added to the
overnight.
(F) K48 chains were assembled with Ube1 and UBE2R1. Time (left to right): 15, 4
(G) K63 chain assembly. Time (left to right): 15 min; 1, 2, 4, and 6 hr; and overnig
See also Figure S3, Table S2, and Data S1.Ub (pSer20), dimers of Ub (pSer57), and dimers of Ub (pSer65)
from each linkage assembly reaction (Figure S3), yielding 27
dimeric substrates for DUB profiling. To profile activity of
DUBs on phosphoubiquitin dimers, we adapted a MALDI-TOF
assay that previously was used to profile DUB activity, speci-
ficity, and inhibition on unmodified Ub dimers (Ritorto et al.,
2014). We followed the extent of phosphorylated diubiquitin
cleavage by the appearance of themonomeric phosphoubiquitin
species in MALDI-TOF, using quantitatively phosphorylated
15N-labeled Ub as an internal standard.
We tested the cleavage of each of the 27 purified Ub dimers
with 31 DUBs in 837 Ub dimer/DUB combinations (Figures 5
and S4). The DUBs profiled included members of the USP,
OTU, and JAMM families that can be purified and assayed
in vitro, and they cover about a third of the DUBs encoded in
the human genome. A potential caveat in interpreting some of
the DUB data comes from the observation that some of the
reactions used to assemble the Ub dimers led to small amounts
of other linkages (Figure S4; Data S1). However, because we
also have data on the cleavage of the other linkages by the
same DUB andmost Ub phosphorylations inhibit DUB cleavage,
the contaminating linkages were not cleaved in most cases.
Therefore, it was still possible to clearly interpret the DUB spec-
ificity data.
DUBs did not cleave the unphosphorylated Ub dimer for 88 of
the Ub dimer linkage/DUB combinations tested. Phosphoryla-
tion of Ub at Ser20, Ser57, or Ser65 did not activate DUB-medi-
ated cleavage of the Ub dimers that were not cleaved when Ub
was unmodified (Figure S4). For the remaining 479 Ub dimer/
DUB combinations, we compared the activity of the DUB on
each phosphorylated Ub dimer to the activity of the DUB on
the unmodified Ub dimer of the same linkage (Figure 5). Most
DUBs tested were less able to cleave the phosphorylated Ub di-
mers. Ser65 phosphorylation led to the greatest reduction of Ub
dimer cleavage by most of the DUBs tested (Figure 5).
Our data define the role of Ub phosphorylation at Ser20,
Ser57, and Ser65 in regulating the DUB-mediated cleavage of
each Ub linkage (Figures 5 and 6). CYLD had comparable activity
on Ub (pSer65) linear Ub dimers and unmodified linear dimers of
Ub, but it wasmuch less active on linear dimers of Ub (pSer20) or
Ub (pSer57) (Figures 5A and 6C).
USP8 cleaved K6-linked dimers of Ub (pSer20) and Ub
(pSer57) more efficiently than K6-linked dimers of Ub, and phos-
phorylation of Ub at residue 65 substantially reduced K6 dimer
cleavage by USP8 (Figures 5B and 6D). In contrast, the cleavagephorylation at Different Sites in Ub
and the E2s, E3s, and DUBs indicated. The protein ladder is Precision Plus All
R(pSer65) were used for these reactions. Time (left to right): 1, 5, 10, 15, 30,
me (left to right): 5, 15, 40, 200, and 360 min and overnight.
night.
reaction after the 6 hr time point. Time (left to right): 0.5, 1, 4, 6, and 8 hr and
5, 120, 240, and 360 min and overnight.
ht.
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Figure 4. UBE3C Is Converted from a Dual-Specificity Ligase to a
K48-Specific Ligase by Phosphorylation of Serine 20 in Ub
(A) Formation of a Ub(20pSer) dimer by Ube1, UBE2D3, and UBE3C followed
by Coomassie staining. No more Ub dimer is detectable after the addition of
the DUB vOTU after the 3-hr time point.
(B and C) Targeted MS using AQUA peptides on purified trimers formed by
Ube1, UBE2D3, and UBE3C, using either unmodified Ub (B) or Ub (pSer20) (C).
See also Figure S1.of K6-linked Ub dimers by USP16 and USP21 was activated by
Ser65 phosphorylation, but not by phosphorylation at Ser20 or
Ser57 (Figures 5B and 6D).
The cleavage of K11-linked Ub dimers by OTUD3 was acti-
vated by phosphorylation of Ser20 in Ub, but it was inhibited
by phosphorylation at Ser57 or Ser65 (Figure 5C). USP4 and
USP5 cleaved K11-linked dimers of Ub with Ser57 or Ser651186 Cell Reports 16, 1180–1193, July 26, 2016phosphorylation, while USP6 cleaved K11-linked Ub dimers
with Ser20 or Ser57 phosphorylation as efficiently as unmodified
K11-linked dimers of Ub, but it was less efficient at cleaving K11-
linked dimers of Ub (pSer65) (Figure 5C). However, the results for
K11 chains with Ser65 phosphorylation must be interpreted with
caution, because these chains contained a substantial amount
of K63-linked Ub (pSer65) (Figure S4; Data S1).
The cleavage of K29-linked dimers by USP2 was activated by
phosphorylation at Ser57, but the cleavage of K29-linked dimers
of Ub by USP2 was deactivated by Ser65 phosphorylation (Fig-
ures 5D and 6E). The USP16-mediated cleavage of K33-linked
Ub dimers was specifically enhanced by phosphorylation at
Ser65 of Ub (Figures 5E and 6F).
The cleavage of K48-linked dimers of Ub by OTU family DUBs
(OTUB1 and OTUB2) and several USP family DUBs (USP4,
USP16, USP21, and VCPIP1) was activated by phosphorylation
of Ser65, but it was deactivated by phosphorylation at Ser20 or
Ser57 (Figures 5F and 6G). The cleavage of K63-linked Ub by
USP8 and USP36 was severely attenuated by phosphorylation
of Ser65 in Ub, but phosphorylation at Ser20 or Ser57 had little
effect on cleavage of K63-linked Ub by these enzymes (Figures
5G and 6H).
Our data also define how each Ub phosphorylation alters the
specificity with which DUBs cleave different Ub linkages (Figures
5 and 6). Ser20 phosphorylation increased OTUD3-mediated
cleavage of K11-linked Ub, but it decreased OTUD3-mediated
cleavage of K48 linkage (Figure 6I). Ser20 phosphorylation
increased USP8-mediated cleavage of K6-linked Ub, but it
decreased the USP8-mediated cleavage of K11 and K48 link-
ages (Figure 6J).
Ser57 phosphorylation increased USP2-mediated cleavage of
K29-linked Ub, but it decreased USP2-mediated cleavage of K6
and K48 linkages (Figure 6K). Ser57 phosphorylation increased
USP6-mediated cleavage of K11-linked Ub, but it decreased
USP6-mediated cleavage of K6, K33, K48, and K63 linkages
(Figure 6L). Ser57 phosphorylation increased USP8-mediated
cleavage of K6-linked Ub, but it decreased USP8-mediated
cleavage of K33 and K48 linkages (Figure 6M).
Ser65 phosphorylation increased OTUB2-mediated cleavage
of K48-linked Ub, but it decreased OTUB2-mediated cleavage
of K63 linkages (Figure 6N). Ser65 phosphorylation increased
USP4-mediated cleavage of K11- and K48-linked Ub, but it
decreased USP4-mediated cleavage of K6-, K29-, and K33-
linked Ub (Figure 6O).
DISCUSSION
We report the synthesis of multi-milligram quantities of Ub phos-
phorylated at position 20, 57, and 65 and the structure of Ub
phosphorylated at Ser20. We report the assembly of K6-,
K11-, K33-, K48-, and K63-linked Ub bearing phosphorylation
at Ser20, Ser57, or Ser65 and the assembly of K29-linked Ub
bearing Ser57 or Ser65 phosphorylation. While we have only
sampled a small subset of possible E3 ligase activities on phos-
phoubiquitin species, our data demonstrate that the site-specific
phosphorylation of Ub can control the extent and isomeric
composition of Ub chains synthesized and that phosphorylation
at distinct sites on Ub have distinct effects on Ub polymer
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Figure 5. Profiling DUB Activity on Isomeric Phospho-Ub Dimers
(A–G) Purified dimers of Ub, Ub (pSer20), Ub (pSer57), and Ub (pSer65) from each linkage assembly reaction (Figure 3) were used to profile deubiquitnase acivity
usingMALDI-TOFMSwith an 15N-labeled Ub internal standard. The activity of each DUB on each phosphorylated Ub dimer, relative to an unmodified Ub dimer of
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dimers are shown.
See also Figures S3 and S4, Tables S2 and S3, and Data S1.synthesis. The most striking observation from the chain assem-
bly experiments is the change in linkage specificity of UBE3C
upon phosphorylation at Ser20 of Ub; this enzyme assembles
K29 and K48 linkages with comparable efficiency when using
Ub as a substrate, but it primarily assembles K48 chains with a
Ub (pSer20) substrate (Figure 6B).
UBE3C associates with the proteasome (Chu et al., 2013). In
response to proteolytic stress, UBE3C is reported to ubiquiti-
nate Rpn13 (a proteasome-resident Ub-binding protein) with
K29-linked chains and decrease the proteasome’s ability to
bind and degrade Ub-conjugated proteins (Besche et al.,
2014). Our results suggest that the phosphorylation of Ser20
in Ub may shut down the formation of K29-linked Ub chains
formed by UBE3C, and this may enable the proteasome toresume proteolysis and aid cellular recovery following proteo-
lytic stress.
Our data provide a wealth of new information on the conse-
quences of Ub phosphorylation on DUB activity. Previous work
investigated the effects of Ser65 phosphorylation on a single
preferred substrate of five DUBs (Wauer et al., 2015), which
does not illuminate the effects of phosphorylation on DUB iso-
peptide linkage specificity. In contrast, we have defined the ef-
fects of phosphorylation at Ser65 (Figure 7A) on the isopeptide
linkage specificity of 31 DUBs. Moreover, we have defined the
consequences of Ser20 and Ser57 phosphorylation (Figure 7A)
for the DUB-mediated cleavage of each Ub linkage. Our data
reveal that (1) phosphorylation at distinct sites in Ub can have
different effects on the cleavage of a particular Ub linkage isomerCell Reports 16, 1180–1193, July 26, 2016 1187
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by a DUB, and that (2) phosphorylation at a single site in Ub can
have a different effect on the cleavage of different Ub linkage iso-
mers by a particular DUB.
DUBs bind to their substrates through a distal Ub-binding
site (which binds the Ub that yields a free carboxylate upon
[iso]peptide cleavage) and a proximal binding site (which yields
a free amine upon cleavage) (Mevissen et al., 2013). The distal
binding site binds Ub in a well-defined orientation, while the
proximal site may allow Ub binding in several orientations to
facilitate the cleavage of different linkage isomers. For several
DUBs (Figure 6), we observed that the cleavage of a particular
Ub linkage isomer is affected differently by phosphorylation at
distinct sites on Ub in the dimer. Phosphorylation may affect
the binding of Ub to the proximal binding site in a DUB, the distal
binding site, or to both sites.
There are structural data for four DUBs with Ub in both the
proximal and the distal binding sites (OTUB1 [Juang et al.,
2012], AMSH-LP [Sato et al., 2008], OTULIN [Keusekotten
et al., 2013], and CYLD [Sato et al., 2015]). In the structure of
OTUB1 and AMSH, which cleave K48 and K63 linkages, respec-
tively, all the serine phosphorylation sites in the distal Ub are
solvent exposed and would not be predicted to directly affect
binding or enzymatic activity (Figure 7B). In contrast, Ser20
and Ser57, but not Ser65, are close to the interface of the prox-
imal Ubwith OTUB1 (Figure 7C), and all sites of serine phosphor-
ylation are close to the interface between AMSH-LP and the
proximal Ub (Figure 7D).
Interestingly, there is a correlation between those phosphory-
lation sites that are close to the interface in the proximal Ub
bound to these enzymes and their inhibition (Figures 5F and
6G). This is consistent with phosphorylation in the proximal Ub
controlling the activity by inhibiting binding or activity (Figure 7E).
The three phosphorylation sites in the Ub bound to the distal
binding site of OTULIN are solvent exposed, consistent with
phosphorylation of the distal Ub not controlling OTULIN activity.
Ser20 and 57 in the proximal Ub are close to the distal Ub bound
to OTULIN, while Ser65 on the proximal Ub is solvent exposed
(Figure S5A). We propose that the OTULIN inhibition on M1 link-
ages observed for Ser20 and Ser57 phosphorylation (Figure 5A),
but not for Ser65 phosphorylation, results from the simultaneous
binding of the distal Ub and phosphorylated proximal Ub being
incompatible on OTULIN. For CYLD, the three phosphorylation
sites in the Ub bound to the distal binding site of CYLD are sol-
vent exposed, and Ser20 and Ser57 also are solvent exposed
in the proximal Ub, while Ser65 interacts with a flexible loop on
CYLD (Figure S5B). Thus, the current structures of CYLD bound
to diubiquitin do not provide an explanation of how phosphoryla-
tion controls Ub linkage cleavage.Figure 6. Synthesis of Phosphorylated Ub and Isomeric Phospho-Ub C
DUB Specificity
(A) The phosphoubiquitin species synthesized. Ub is symbolized by a light gray cir
[pSer20]), orange (Ub [pSer57]), or blue (Ub [pSer65]) circle. Each linkage is symb
K33, dark blue; K48, orange; and K63, gray.
(B) Phosphorylation of Ser20 converts UBE3C from a dual-specificity E3 ligase t
(C–H) Phosphorylation at Ser20, Ser57, and Ser65 of Ub has distinct effects on the
for the indicated phosphoubiquitin dimer and are color coded as in Figure 5.
(I–O) Phosphorylation controls the specificity of Ub isomer cleavage by DUBs.For many DUBs tested, phosphorylation at one site inhibits
the cleavage of all the Ub linkage isomers tested, with Ser65
phosphorylation of Ub leading to the greatest inhibition of
DUB activity in most cases. The simplest explanation for these
observations is that each phosphorylation has a defined effect
on the activity of each DUB, by controlling Ub binding, regard-
less of the linkage isomer, at the distal binding site. This model
is supported by the structure of Ub bound to the distal site of
USP2 (Figure 7F), an enzyme that is inhibited from cleaving
all Ub linkages by phosphorylation of Ser65 (Figure 5). Ser65
of the distal Ub is buried at the interface with USP2, and we
suggest that phosphorylation of USP2 may control the cleav-
age of all Ub linkages by inhibiting binding of the distal Ub
(Figure 7G).
For some DUBs (OTUD3, USP8, USP2, USP6, OTUB2, and,
USP4) (Figures 6I–6O), the phosphorylation of Ub at a particular
site can enhance the cleavage of a Ub linkage isomer, while
phosphorylation at the same site in a different Ub linkage
isomer can reduce the cleavage mediated by the same DUB.
The differential cleavage of site-specifically phosphorylated
Ub dimers as a function of linkage isomer is consistent with
the phosphorylation affecting binding in the proximal Ub-
binding site, where different isomers are bound in different
orientations, rather than in the distal Ub-binding site, where
Ub is bound in a common orientation. Consistent with this
hypothesis, the structures of USP2, USP8, and OTUB2 with
Ub bound in the distal binding site reveal that the relevant
serine residues (Ser57 for USP2, Figure 6K; Ser20 and 57 for
USP8, Figures 6J and 6M; and Ser65 for OTUB2, Figure 6N)
are solvent exposed in the distal binding sites (Figure 7H).
We conclude that specific phosphorylations on Ub may control
the linkage specificity of DUBs by regulating the binding of
selected isomers in the proximal binding site of the DUB
(Figure 7I).
We demonstrate that the cleavage of a Ub linkage typemay be
regulated by phosphorylation of Ub and that phosphorylation at
different sites in Ub can have distinct effects on the cleavage of
a linkage. Since phosphorylation of serine residues in Ub
commonly inhibits DUB activity but has less effect on the subset
of Ub chain synthesis enzymes tested, we suggest that phos-
phorylation may regulate the levels of Ub chains, primarily
through effects on DUB activity and specificity.EXPERIMENTAL PROCEDURES
Purification of E1, E2, E3, DUB, 15N-Ub, and Ub oligomers were by standard
methods (Faggiano et al., 2016; Ritorto et al., 2014) and are described in the
Supplemental Experimental Procedures. MS, MALDI-TOF assays (Ritortohains Reveals the Effects of Ub Phosphorylation on E3 Ligase and
cle on which each phosphorylated residue is symbolized by a smaller green (Ub
olized by a colored line as follows: M1, red; K6, blue; K11, yellow; K29, green;
o a K48-specific E3 ligase.
cleavage of Ub linkages. The arrows indicate the efficiency of linkage cleavage
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Figure 7. Structural Models for the Control of DUB Specificity by Phosphorylation
(A) Cartoon representation of Ub. The positions of the phosphate groups are represented by a green (pSer20), orange (pSer57), or blue (pSer65) circle. The same
color scheme is used throughout the figure.
(B) The structure of OTUB1 in complex with proximal and distal Ub linked through a K48 isopeptide bond (PDB: 4DDG [Juang et al., 2012]). The position of each
phosphorylation on the proximal and distal Ub is color coded.
(legend continued on next page)
1190 Cell Reports 16, 1180–1193, July 26, 2016
et al., 2014), and targeted parallel reaction monitoring MS are detailed in the
Supplemental Experimental Procedures.
Expression and Purification of Phosphorylated Ub Variants
BL21 DserB(DE3) cells containing pKW2 EF-Sep and pNHD-Ub (described in
Rogerson et al., 2015) containing Ub-His6, UbK48R-His6, Ub20TAG-His6,
Ub20TAG:K48R-His6, Ub57TAG-His6, Ub57TAG:K48R-His6, Ub65TAG-His6,
or Ub65TAG:K48R-His6 were grown overnight at 37
C in terrific broth (TB)
media containing 50 mg/ml chloramphenicol and 25 mg/ml tetracycline. The
culture was diluted 1:100 into fresh TB media containing 25 mg/ml chloram-
phenicol and 12.5 mg/ml tetracycline and incubated at 37C; once the OD600
reached 0.5, dexfosfoserine (pSer) (Bachem) was added to a final concentra-
tion of 2 mM. After 30 min of further incubation, additional pSer was added
to the culture to reach a final concentration of 4 mM, and the culture was
induced using 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) at 37C
for 6 hr.
Cells were harvested by centrifugation, resuspended in 50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 30 mM imidazole, 0.5 mg/ml lysozyme (Sigma), and
50 mg/ml DNase (Sigma), and lysed by sonication. The lysate was clarified
by centrifugation at 39,0003 g for 30 min and filtration through a 0.4 mm poly-
ethersulfone (PES) membrane. Ub was purified using nickel affinity chroma-
tography (HisTrap HP column, GE Healthcare) with a linear gradient of
imidazole (30–500 mM). The protein was dialysed overnight against 10 mM
Tris-HCl at 4C, the C-terminal His6-tag was removed by incubating the sam-
ple with 15 mg/ml UCHL3 at 37C for 5 hr, and Ub was further purified by ion
exchange chromatography (MonoS 4.6/100 PE column, GE Healthcare), using
an NaCl gradient (0–500 mM) in 50 mM ammonium acetate (pH 4.5). Pure frac-
tions were confirmed by ESI-MS and pooled before overnight dialysis against
20mM Tris-HCl (pH 7.4). The sample was then concentrated to15mg/ml us-
ing Amicon Ultra-15 (3 kDa molecular weight cut off [MWCO]) centrifugal filter
device (Millipore). All purifications were performed at 4C.
Crystallographic Analysis of Ub (pSer20)
Purified Ub (pSer20) in 20 mM Tris (pH 7.4) was crystallized at 10 mg/ml in a
hanging-drop setup using the vapor diffusion method. Crystals grew in 45%
(w/v) PEG 400 and 100 mM Tris-HCl (pH 7.0), and they were vitrified in the
same mother liquor. Data were collected at the ID-29 beamline at the Euro-
pean Synchrotron Radiation Facility (ESRF). The structure was determined
bymolecular replacement in Phaser (McCoy et al., 2007), using a searchmodel
of Ub (PDB: 1UBQ [Vijay-Kumar et al., 1987]) that lacked the last five flexible
C-terminal residues. Model building and refinement were carried out in Coot
(Emsley et al., 2010) and Phenix (Adams et al., 2010, 2011), respectively.
The final statistics are shown in Table S1.
ACCESSION NUMBERS
The accession number for the crystal structure reported in this paper is PDB:
5K9P.(C) The site of phosphorylation on the proximal, but not distal, Ubmay control the
andUb linkages and phosphorylations are color coded as in Figure 6. Each DUB is
is activation of DUB activity with respect to a non-phosphorylated Ub substrate)
(D) The structure of AMSH-LP in complex with proximal and distal Ub linked throug
on the proximal and distal Ub is color coded.
(E) The site of phosphorylation on the proximal, but not distal, Ubmay control the s
coded as in Figure 6.
(F) The structure of USP2 in complex with Ub bound at the distal site (PDB: 2HD
(G) Phosphorylation on the distal Ub in USP2 may inhibit cleavage of all Ub linka
(H) The structures of USP8 (PDB: 3N3K [Ernst et al., 2013]), OTUB2 (PDB:4FJV
distal Ub. The sites of phosphorylation that activate the cleavage of one linkage b
shown for each complex with the distal Ub. The sites of phosphorylation lie far from
these enzymes, specificity is controlled through the proximal Ub.
(I) Linkage specificity may be controlled by site-specific phosphorylation contro
activating.
See also Figure S5.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, three tables, and one data file and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2016.06.064.
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